Učitavanje...

Pembrolizumab-Induced Mobitz Type 2 Second-Degree Atrioventricular Block

Pembrolizumab is a monoclonal antibody directed towards programmed cell death protein 1 (PD-1) and is an antineoplastic drug which has a growing variety of oncologic uses. Pembrolizumab is commonly associated with immune-related adverse events (IRAEs) but is infrequently noted to cause cardiotoxicit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Case Rep Cardiol
Glavni autori: Khan, Alisha, Riaz, Sana, Carhart, Robert
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007942/
https://ncbi.nlm.nih.gov/pubmed/32047674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8428210
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!